October 31 2023 - The 2023 Biotech Graveyard

The 2023 Biotech Graveyard
GSK to pay $1 bln for exclusive license to J&J's hepatitis B therapy
Sarepta’s disappointing data put the FDA in a difficult spot
A continuing decline in sales of COVID-19 products clips revenue at Pfizer
*please scroll down for all the latest news*

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud